Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
TScan Therapeutics, Inc. (TCRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2023 |
4
| BARBERICH TIMOTHY J (Director) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.66, valued at
$93.1k
|
|
| 06/15/2023 |
4
| Barton Debora (Chief Medical Officer) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 430,000 options to buy
@ $2.49, valued at
$1.1M
|
|
| 06/15/2023 |
4
| Dorton Katina (Director) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.66, valued at
$93.1k
|
|
| 06/15/2023 |
4
| Gruia Gabriela (Director) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.66, valued at
$93.1k
|
|
| 06/15/2023 |
4
| Klencke Barbara (Director) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 36,524 options to buy
@ $2.66, valued at
$97.2k
|
|
| 06/15/2023 |
4
| Silver Brian M. (CFO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 632,500 options to buy
@ $2.49, valued at
$1.6M
|
|
| 06/15/2023 |
4
| MacBeath Gavin (CEO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 1,121,300 options to buy
@ $2.49, valued at
$2.8M
|
|
| 06/15/2023 |
4
| ZDRAVESKI ZORAN (Chief Legal Officer) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 430,000 options to buy
@ $2.49, valued at
$1.1M
|
|
| 06/06/2023 |
4
| BARBERICH TIMOTHY J (Director) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Bought 37,880 shares
@ $2.6284, valued at
$99.6k
|
|
| 06/02/2023 |
4
| Lynx1 Capital Management LP (10% Owner) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $2.5148, valued at
$25.1k
Sold 15,000 shares
@ $2.5201, valued at
$37.8k
Sold 400 shares
@ $2.5075, valued at
$1k
|
|
| 02/06/2023 |
4
| SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.81, valued at
$181k
|
|
| 02/06/2023 |
4
| MacBeath Gavin (See Remarks) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.81, valued at
$72.4k
|
|
| 02/06/2023 |
4
| ZDRAVESKI ZORAN (Chief Legal Officer) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.81, valued at
$63.4k
|
|
| 02/06/2023 |
4
| Barton Debora (Chief Medical Officer) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.81, valued at
$90.5k
|
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2022 |
4
| Desmarais William (Chief Business Officer) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.27, valued at
$98.1k
|
|
| 07/27/2022 |
4
| Silver Brian M. (CFO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 220,000 options to buy
@ $3.27, valued at
$719.4k
|
|
| 07/27/2022 |
4
| ZDRAVESKI ZORAN (Chief Legal Officer) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.27, valued at
$163.5k
|
|
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Gruia Gabriela (Director) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 9,146 options to buy
@ $3.17, valued at
$29k
|
|
| 06/03/2022 |
4
| Harel Ittai (Director) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 9,146 options to buy
@ $3.17, valued at
$29k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| Silver Brian M. (CFO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $3.3988, valued at
$51k
|
|
| 01/20/2022 |
4
| Desmarais William (Chief Business Officer) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.85, valued at
$242.5k
|
|
| 01/20/2022 |
4
| MacBeath Gavin (Chief Scientific Officer) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 140,000 options to buy
@ $4.85, valued at
$679k
|
|
| 01/20/2022 |
4
| Silver Brian M. (CFO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 115,000 options to buy
@ $4.85, valued at
$557.8k
|
|
| 01/20/2022 |
4
| SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 275,000 options to buy
@ $4.85, valued at
$1.3M
|
|
|
|
|